FDA advisers overrode their own scientists to back 6 peptides for compounding, even as safety data remains thin and gray-market risks persist.
5 Things to Know About the FDA's Peptide Reversal
Comment
Show comments
Hide Comments
FDA advisers overrode their own scientists to back 6 peptides for compounding, even as safety data remains thin and gray-market risks persist.
